BioAge Labs (BIOA) Total Liabilities (2023 - 2026)

BioAge Labs has disclosed Total Liabilities across 4 years of filings, most recently posting $18.5 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $18.5 million, down 39.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.5 million (down 39.58% YoY), and the FY2025 annual result was $22.8 million, down 34.95% from the prior year.
• Total Liabilities came in at $18.5 million for Q1 2026 at BioAge Labs, down from $22.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $197.1 million in Q2 2024 to a low of $18.5 million in Q1 2026.
• The 4-year median for Total Liabilities is $30.7 million (2025), against an average of $71.7 million.
• Peak annual rise in Total Liabilities reached 16.9% in 2025, while the deepest fall reached 86.12% in 2025.
• BioAge Labs' Total Liabilities stood at $66.6 million in 2023, then plunged by 47.29% to $35.1 million in 2024, then plunged by 34.95% to $22.8 million in 2025, then dropped by 18.85% to $18.5 million in 2026.
• The last three Total Liabilities figures came in at $18.5 million (Q1 2026), $22.8 million (Q4 2025), and $27.6 million (Q3 2025), per Business Quant data.